ASCO 2020May 29, 2020
The Epic Sciences team will be presenting at the virtual ASCO 2020 Annual Meeting – From May 29 – 31, 2020.
The following are details of the abstract and poster virtual sessions, which are also available at www.asco.org
Abstract 5531/Poster 112: Genitourinary Cancer Poster Session: Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole-genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC).
Abstract 5571/Poster 152: Genitourinary Cancer Poster Session: Clinical significance of CTC enumeration on the Epic Sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients treated with AR signaling inhibitors (ARSi).
Abstract 5571/Poster 152 – Video
Abstract 5572/Poster 153: Genitourinary Cancer Poster Session: Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane.
Abstract 5572/Poster 153 – Video